Margaret McLoughlin, Director at Cortexyme, Inc. (CRTX), bought 550 shares at $17.00 ($9K) on 2019-05-13, disclosed to the SEC on 2020-03-12.
Open-market purchase of $9k CRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CRTX | SELL | 2021-08-18 | $1.1M | — | Filing → |
| CRTX | SELL | 2021-06-29 | $30K | — | Filing → |